Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modeled Dose Exposure of Sublingual Buprenorphine in the Neonatal Opioid Abstinence Syndrome

NCT03608696 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03608696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03608696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modeled Dose Exposure of Sublingual Buprenorphine in the Neonatal Opioid Abstinence Syndrome
Lead sponsor
Thomas Jefferson University
Phase
Phase 1/2
Overall status
Completed
Start date
August 29, 2018
Completion date
July 11, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal abstinence syndrome, neonatal opiate withdrawal syndrome